Market Report, "Malignant Pleural Mesothelioma - Pipeline Review, H2 2013", Published
Global Markets Direct's, 'Malignant Pleural Mesothelioma - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Malignant Pleural Mesothelioma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Malignant Pleural Mesothelioma. Malignant Pleural Mesothelioma - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites,...
View full press release